TABLE 2

Plasma hormones and glucose during baseline and during intervention

GroupInsulin (pmol/l)Cortisol (μg/dl)Glucagon (pg/ml)GH (ng/ml)Glucose (mmol/l)Arterial AAs (μmol/l)
LeucinePhenylalalineTyrosineTotal AAsKIC
NS
 Baseline29 ± 414.3 ± 2.342 ± 52.2 ± 1.45.1 ± 0.1131 ± 849 ± 346 ± 41,911 ± 16234 ± 3
 Intervention22 ± 211.8 ± 2.541 ± 41.3 ± 0.44.9 ± 0.1137 ± 749 ± 345 ± 41,886 ± 16633 ± 3
Ins
 Baseline32 ± 622.8 ± 4.949 ± 131.3 ± 1.05.0 ± 0.1113 ± 648 ± 350 ± 91,611 ± 15731 ± 2
 Intervention159 ± 8*17.0 ± 3.248 ± 99.0 ± 4.34.6 ± 0.163 ± 5*40 ± 2*34 ± 4*1,345 ± 152*15 ± 1*
LoAA/Ins
 Baseline32 ± 212.4 ± 2.047 ± 63.1 ± 1.85.0 ± 0.1112 ± 848 ± 255 ± 51,790 ± 14928 ± 4
 Intervention171 ± 9*13.2 ± 2.459 ± 107.4 ± 2.84.6 ± 0.1168 ± 2561 ± 548 ± 51,984 ± 17024 ± 4
HiAA/Ins
 Baseline33 ± 811.8 ± 2.351 ± 100.8 ± 0.15.0 ± 0.1106 ± 844 ± 345 ± 51,796 ± 15425 ± 2
 Intervention182 ± 10*15.9 ± 0.897 ± 10*7.5 ± 3.24.8 ± 0.1392 ± 19*100 ± 6*51 ± 72,937 ± 172*33 ± 3*
SRIH-AA
 Baseline58 ± 614 ± 247 ± 90.7 ± 0.15.8 ± 0.5112 ± 950 ± 246 ± 41,501 ± 11926 ± 2
 Intervention59 ± 616 ± 258 ± 61.0 ± 0.25.0 ± 0.1312 ± 14*102 ± 3*56 ± 3*2,611 ± 299*35 ± 4*
SRIH/NS
 Baseline59 ± 414 ± 444 ± 70.8 ± 0.15.2 ± 0.3103 ± 450 ± 142 ± 31,320 ± 5726 ± 3
 Intervention57 ± 414 ± 342 ± 70.9 ± 0.15.1 ± 0.390 ± 448 ± 142 ± 41,268 ± 6220 ± 3
  • Data are means ± SE.

  • *

    * P < 0.001 vs. baseline;

  • P < 0.01 vs. all other groups. GH, growth hormone.